12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Inavir laninamivir regulatory update

Japan approved Daiichi's Inavir laninamivir dry powder inhaler to treat influenza A and B in adults and children. Daiichi...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >